Market Overview
The Prokaryotic Recombinant Protein Market is expected to experience steady growth, with projections estimating an increase from USD 2,725.2 million in 2024 to approximately USD 4,278.42 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.8% over the forecast period from 2024 to 2032. The market is driven by various factors, including the rising demand for biologics, increased investments in drug development, and the growing application of recombinant proteins in